BlueCrest Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,532,882
| Closed | -$138M | – | 92 |
|
|
2024
Q4 | $138M | Buy |
+1,532,882
| New | +$138M | 3.89% | 3 |
|
|
2018
Q3 | – | Sell |
-18,787
| Closed | -$1.79M | – | 1805 |
|
|
2018
Q2 | $1.79M | Buy |
+18,787
| New | +$1.79M | 0.05% | 313 |
|
|
2018
Q1 | – | Sell |
-49,866
| Closed | -$4.23M | – | 1629 |
|
|
2017
Q4 | $4.23M | Sell |
49,866
-19,568
| -28% | -$1.66M | 0.12% | 167 |
|
|
2017
Q3 | $6.01M | Buy |
69,434
+57,887
| +501% | +$5.01M | 0.24% | 98 |
|
|
2017
Q2 | $891K | Buy |
+11,547
| New | +$891K | 0.03% | 463 |
|